What is Myriad Genetics Inc (MYGN)?
Myriad Genetics Inc is a molecular diagnostic company specializing in genetic testing and precision medicine. The company develops and markets tests that assess the risk of developing various hereditary conditions, including cancers and other diseases. Its offerings include tests for hereditary cancer risk assessment, pharmacogenomics, and companion diagnostics. Myriad Genetics also provides clinical services that support personalized treatment plans based on genetic information. The company operates in the healthcare sector, focusing on advancing the understanding of genetics to improve patient outcomes. Its products and services are utilized by healthcare providers, researchers, and patients to inform medical decisions and disease management strategies. The company engages in research and development activities aimed at expanding its portfolio of genetic tests and enhancing the clinical utility of its offerings. It operates through various business segments that address different aspects of genetic testing and diagnostics. Myriad Genetics is headquartered in the United States and serves a global customer base.
Myriad Genetics Inc Stock Price Today: Live Overview
The price today is shaped by active market participation, as Myriad Genetics Inc trades at $4.62. It has seen its value range from $4.52 to $4.83, with a daily change of 0%.
FAQ: Myriad Genetics Inc (MYGN)
What is the current price of MYGN stock?
Myriad Genetics Inc's current price is $4.62.
Does MYGN pay dividends?
Myriad Genetics Inc does not currently pay dividends.
Does MYGN have a formal corporate presence or regional headquarters in the UAE?
Myriad Genetics Inc operates in the UAE through partnerships without an official regional office.
What is MYGN best known for?
Myriad Genetics Inc is most famous for its molecular diagnostic tests and genetic testing services.
What assets are typically shown together with MYGN?
Commonly shown alongside MYGN: Axogen Inc, Illumina, Omnicell Inc
Latest shares articles



